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Cryptococcus neoformans is an environmental, fungal pathogen responsible for 
around 15% of AID-related deaths.1–3 The primary virulence factor of C. neoformans is a 
polysaccharide (PS) capsule that inhibits phagocytosis by immune cells, interferes with 
complement, inhibits antibody production, and is necessary to cause disease.3–6 The PS 
capsule is also the main drug and vaccine target. Even with current methods of isolation, 
the PS of C. neoformans has not been fully characterized. Throughout this work I will 
describe two novel methods of examining the PS of C. neoformans, sonication-induced 
cavitation to isolate the PS capsule, and neutron scattering to assess its structure. 
Cavitation, occurs when a bubble pops and the empty space is rapidly filled, induced by 
sonication was able to shave off the PS capsule. Released PS was detectable in the 
supernatant of sonicated samples, and antibody binding to the capsule still attached to the 
cell wall increased post-sonication. Neutron scattering was performed, for the first time, 
on the PS of C. neoformans, in collaboration with Dr. Susana Teixeira from the National 
Institute of Standards and Technology (NIST). There was no scattering from the PS in 
H2O and slight scattering from the sample in D2O. More work needs to be done to 
prepare samples used for neutron scattering before any conclusions can be made from the 
data. Novel techniques, such as those mentioned above, are important the continued 
characterization of the PS of C. neoformans, as well as for the discovery of more drug 
and vaccine targets.  
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1.1 Thesis Statement 
  
New methods are needed to study the polysaccharide (PS) capsule of the fungal 
pathogen Cryptococcus neoformans. The PS capsule is the key to C. neoformans 
virulence, but due to its fragility, the PS capsule is difficult to characterize and the 
structure is unknown.3,5,7,8 In this thesis I will describe two new methods, neutron beam 
scattering and sonication, for pursuing the structure of PS in the C. neoformans capsule 
and how these findings can advance efforts to characterize the PS capsule, why the use of 
findings from new techniques are of significance, and what are the next steps for 
continuation of this line of inquiry.  
 
1.2 Background  
 
Cryptococcus neoformans is an opportunistic fungal pathogen that causes 
cryptococcosis and can lead to cryptococcal meningitis.7 It infects mainly 
immunocompromised individuals, particularly those living with HIV and AIDS.2,9 C. 
neoformans has multiple virulence factors. The most important virulence factor is the 
polysaccharide (PS) capsule, which forms outside the cell wall of C. neoformans.10 
Another key virulence factor for C. neoformans is the ability to form a melanin layer in-
between the cell membrane and cell wall.8,11 
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1.3 Virulence Factors of C. neoformans 
 
The PS capsule is essential to causing disease in the host organism.7,8,11 Without 
the PS capsule C. neoformans is avirulent.8  The PS capsule enables C. neoformans to 
inhibit and evade the immune system through the following mechanisms.8,13,14 
• Providing protection against host immune defenses; 
• Inhibiting phagocytosis by macrophages; 
• Inhibiting antibody production;  
• Interfering with opsonic deposition of complement.  
Because the PS capsule is the  main virulence factor in C. neoformans; it is also the 
target for the development of therapeutic techniques and potential vaccines, as well as a 
medical biomarker for diagnosis.3 The capsule structure is particularly difficult to study 
because of its highly branched structure, composition4, and fragility—all of which 
contribute to the difficulty of understanding the PS capsule in sufficient detail to develop 
an effective vaccine and therapeutic treatments. Most of the information about the 
capsular PS has been generated through the study of exopolysaccharide, which is released 
from C. neoformans in culture and can be removed and purified through several 
techniques.3 
The ability to melanize is another critical virulence mechanism of C. 
neoformans.11,15,16 The ability of C. neoformans to produce melanin can protect the 
pathogen from free-radical damage, oxidizing agents, and reduce the effects of 
amphotericin B, therefore increasing the pathogen’s resistance to mammalian 
macrophages.15,17,18 These are potential sources of damage to C. neoformans that can be 




1.4  Composition of the PS Capsule  
 
The PS capsule can grow several fold larger than the yeast cell diameter. Most of the 
PS capsule volume is comprised of water; the total mass and volume of the PS capsule is 
between 95% and 99% water.6 This high water content makes the capsule prone to 
dehydration when studied using high resolution microscopy.6,27 The PS capsule appears 
to be made up of layers, and is not uniform throughout its structure.28 The PS component 
of the capsule is mainly glucuronoxylomannan (GXM) and glucuronoxylomannogalactan 
(GXM-Gal). GXM is the main PS in the capsule, making up 90-95% of polysaccharide 
components; GalXM comprises 5-8%.29 Components of GXM are used as a targets for 
antibodies, which are used in detection and determining prognosis.30,31 Mannoproteins 
have also been identified as capsular components, although their localization is generally 
at or near the cell wall. Other capsular proteins that have been identified include  LHC1.3  
There are two different genetically related subspecies of C. neoformans: C. 
neoformans var. neoformans and C. neoformans var. gatti. The two subspecies can be 
subdivided into four serological serotypes based on antibody reactivity to the GXM 
protein component. C. neoformans var. neoformans is made up of serotypes A, D, and 
A/D. Subgroup A includes H99, a common lab strain. Serotype A also makes up the 
majority of clinical isolates from cryptococcal infections in AIDS patient.32 C. 
neoformans var. gatti is made up of serotypes B and C. For this project subgroup A, C. 
neoformans var. neoformans, strain H99 was used for all experiments. 
The primary structure of GXM is made up of a linear (1→3)--D-mannopyranan 
bearing -D-xylopyranosyl (Xylp), -D-glucopyranosyluronic acid (GlcpA), and 6-O-
acetyl substituents 14,32 (Figure 4) The location of the O-acetyl substituents is the major 
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The primary structural components of GXM, derived from the use of NMR, were 
later confirmed and built upon through the use of mass spectrometry (MS). Using MS, 
the chemical components in the sample are ionized and sorted to determine mass-to-
charge ratios.37 The MS results confirmed the Man/GlcA ratio of GXM-derived 
oligosaccharides matched up with the 3:1 ratio that was hypothesized using NMR. This 
method also confirmed the GXM triad pattern shown in figure 4. The use of MS also 
provided new, important findings regarding the structure of the GXM molecule: the 
molecule can contain multiple triads of the six mannosyl triads available (Figure 4), the 
structure is highly heterogeneous, and can change depending on cell cycle and 
conditions.38 
Two other methods that have been used to aid in the characterization of the PS 
capsule of C. neoformans are static light scattering (SLS) and dynamic light scattering 
(DLS). Both SLS and DLS measure how light is scattered through a sample. DLS works 
by changing the wavelength of the light. In SLS the concentration of the sample changes, 
and the wave length of light remains constant.39 SLS and DLS are particularly 
advantageous for studying the PS capsule because they are non-destructive methods, and 
the sample remains in solution. Therefore, the data better reflects the PS in its native, 
hydrated state. SLS and DLS have been used to determine the average-molecular mass 
(Mw); mean-square radius of gyration (Rg); hydrodynamic radius (Rh); and 
polydispersity.4 These methods confirmed the previously suspected highly branched 




1.5 Progress Toward Understanding the Structure of the PS Capsule 
 
Despite the obstacle of capsular PS fragility there are methods to isolate it from the 
cell wall. However, these methods produce inconsistent results with one another (Table 
1) This is due to the isolation methods themselves altering the PS of C. neoformans, 
which destroy the native composition and structure of the PS.  
Two frequently used methods of capsular PS isolation involve the use of dimethyl 
sulfoxide (DMSO) and gamma radiation.40,41 DMSO is quite a simple procedure where 
DMSO is added to C. neoformans cells, then the DMSO is dialyzed out leaving only the 
capsular PS. This method produces a high molecular weight PS (Table 1). This method is 
that it does not fully remove the PS capsule from C. neoformans, the inner most layer is 
still attached to the cell wall when observed with light microscopy. To completely 




essentially a bathtub where sound, emitting from all sides, induces cavitation within the 
water bath. The solid sample (or jewelry, or glasses) is placed in the water for a period of 
time to be lysed or cleaned. This method can take up to a few hours to fully work without 
the sample overheating. The downsides of this method are the low energy output; the 
time it takes to be fully effective; and that the cavitation cannot be focused. The probe or 
horn sonicator, which will be referred to later, uses the same basic idea except the sound 
waves are focused through a metal probe. The probe can be put into a liquid and induce 
cavitation. Horn sonicators reach higher energy outputs than the water bath sonicators, 
take less time to be effective, but also cause a rise in the temperature of the sample. 
 
2.2 Small Angle Neutron Scattering  
 
To analyze the structure of exo-PS of C. neoformans we utilized the novel technique 
of neutron beam scattering. Ultra-small angle neutron scattering (USANS) and small 
angle neutron scattering (SANS) to characterize the PS of C. neoformans is being studied 
in collaboration with Dr. Susana Teixeira from the National Institute of Standards and 
Technology (NIST). These techniques used to study the structural information below 
100nm.45,46 Neutrons are non-ionizing, and thus, make excellent probes into matter, with 
tunable energies that cover a wide range of resolutions. They are also able to penetrate 
most materials non-destructively. The initial readout is a sigmoidal curve if signal is 
detectable, if there is no scattering it is a flat line. Any peaks of troughs in the curve 
correspond to possible structural components in the sample.45–47 After the initial readout 
the data is reduced and fit to a model to continue characterization.  
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The ability to substitute deuterium, a stable isotope of hydrogen also called heavy 
water, with the labile hydrogen atoms within the sample allows for a better signal-to-
noise ratio. This is because the deuterium isotype has a stronger coherent scattering 
(signal) and does not contribute to background noise as much as H. H/D exchange is 
performed with the use of D2O in the buffer which the sample is contained. Different 
contrasts (difference between the neutron scattering length density (SLD) of the molecule 
of interest in the sample, and the SLD of the buffer) are assessed by using a varying per 
cent of D2O. This creates a difference in the scattering pattern where differences are 
highlighted, and certain components are matched out (zero-contrast). The q (scattering 
intensity) ranges for USANS are 0.00003-0.001 (inverse Angstrom) 45 and for SANS 
0.001 to 0.4 (inverse Ang).48 Data were reduced and analyzed with the NCNR, NIST 
Center for Neutron Research, macros for Igor Pro2.47  
 
  
                                                 
2 Access to USANS and NGB30SANS instruments was provided by the Center for High Resolution Neutron Scattering, a 
partnership between the National Institute of Standards and Technology and the National Science Foundation under 
Agreement No. DMR-1508249. 
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Materials and Methods 
 
Cultures  
 A 6ml pre-culture of C. neoformans strain H99 was made in Sabouraud dextrose 
broth media. This pre-culture was incubated on a circulating rack for 24 h at 30°C. The 
cells were then washed three times with minimal media (15mM D-glucose, 10mM 
MgSO4• 7 H2O, 20.3 KH2PO4, 3mM Glycine, 10mg/mL Thiamine). After washing, the 
cells were resuspended in 6mL of minimal media. Half (3mL) of the washed cells were 
inoculated into a flask with 500 mL of minimal media to grow the non-melanized C. 
neoformans. The other 3mL of pre-culture was inoculated into a flask containing 500mL 
minimal media containing 100mg of L-3,4-dihydroxyphenylalanine (L-dopa). These 
flasks were incubated in a 30°C shaker. The cultures were used at 3, 5, and 7 days. 
 
Sonication 
 A volume of 40mL, approximately 1x108 cells/mL, of each 500mL culture were 
collected then washed with 1% PBS to remove all the spent minimal media. Cells were 
centrifuged at 15.6g for 7 minutes. Cells were counted and brought to a density of, or 
around, 1x108 cell/mL in 1% PBS. From here, 2mL of the diluted cell suspension were 
put into glass tubes (volume and brand?). These tubes were then ultra-sonicated with the 
use of a horn sonicator (Fisher Scientific Sonic Dismembrator F550 W/ultrasonic 
Convertor) for 30 seconds. Each sample was sonicated at one of the watts (RMS, root-
mean-squared) levels (1-10) with tubes left unsonicated for control purposes. Watts 
(RMS) corresponds to a continues output of energy by taking several watt measurements 
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squaring each value, to determine the average, then finding the square root. Level 7 was 
the one that was primarily used.  Post sonication cellular samples were used to do a 
“tadpoling” survival assay. Tadpoling49 is an assay that determines whether the cells 
survived the treatment or not. It measures colony growth after a period of time. Treated 
samples were centrifuged at 13.3 g for 12 minutes. The supernatant was collected, and 
the pellet was used for microscopy.   
 
Survival Analysis 
A tadpoling assay was used to evaluate yeast survival after sonication. This assay 
was adapted from Welch and Koshland, 2013 49. A volume of 300 µL of each sample 
were placed in the first row of a 96-well plate in triplicate. 200 µL of Sabouraud dextrose 
broth was placed in the rest of the rows. The samples were serially diluted (1:3) down the 
rows. Sterile water was used as a control. Plates were placed in a 30°C incubator for 24-
hours. Plates were imaged using and immunocapture 6.3.  
Using ImageJ, the mean grey area was calculated from rows B-H on the 96-well 
plate was determine. This number corresponds to the number of colonies in the space 
with a lower number corresponding to fewer colonies. An average level of background 
was subtracted from the values attainted to account for the color of the media in the 
wells. These data points were then normalized with the first 1:3 dilution of the control 
being 100%. From here survival curves were generated for non-melanized and melanized 





 Light microscopy images of C. neoformans pre and post sonication were taken by 
mixing 3uL of the centrifuged cell pellet with 6uL of India Ink. Images were taken using 
(Microscope).  
 
Dynamic Light Scattering (DLS) 
 Polydispersity and effective diameter of samples was measured using a Zeta 
Potential Analyzer (Brookhaven Instruments Corporation). The methods used were 
described in Frases et al., 20094,10. 
 
GXM Capture ELISA 50  
This method was adapted from Casadevall et al., 1992 50. Using a 96-well 
microtiter plate the wells were coated with 50ul/well of a 1-10ug/mL solution of anti-
CNPS/GXM mAB, known as 2D10. This solution was prepared using 1X PBS. Plates 
were incubated for 1 hour at 37°C. Plates were blocked with a 1% BSA solution 
(prepared in 1X PBS) 200 l/well, overnight at 4°C. A 10ug/mL GXM standard was used 
for the standard curve. 75ul of sample or standard was added to the first well in each 
column, then 25ul was serially diluted into 50ul of 1X PBS horizontally across the plate. 
The plate was then incubated at 37°C for one hour. Plates were then washed 3 times with 
0.1% TWEEN-20 in TBS. Next 50 l/well of an anti-CNPS/GXM mAB of a different 
isotype than the initial one, 18B7, was diluted to a concentration of 2 l/mL in blocking 
solution and added to the wells. The plate was then incubated at 37°C for one hour or at 
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4°C overnight. Plate was then washed 3 times with the same solution previously 
mentioned.  
Then 50ul/well of a 1:1000 dilution of alkaline phosphatase labeled anti-Fc Ab 
that would recognize the mAb 18B7 (IgG1), was added, dilutions were again made in 
blocking solution. Plate was then incubated at 37°C for one hour or at 4°C overnight. 
Plate was then washed 5 times with the above solution. 50 l/well of 1 mg/ml alkaline 
phosphatase substrate (p-nitrophenyl phosphate) in substrate buffer were then added. 
Plates were given time at room temperature to develop then read at A405. The amount of 
GXM in each sample was determined by plotting the standard along a logarithmic x-axis. 
The linear portion of that s-curve was then fitted with a linear regression line. Only 
samples with absorbances in this linear range were used to calculate the total GXM in the 
sample. This was done by plugging the absorbance into the equation given by the linear 
regression, multiplying by the dilution of the sample, then multiplying by the volume the 
sample was initially resuspended in. 
 
Phenol-Sulfuric Acid Assay 51 
This assay was developed from Maskuko et al., 2005. To start 100μl of 1M 
mannose was 1:2 serially diluted into 50μl of sterile water in the first three columns of a 
96-well plate. 50μl of each sample was put into three wells undiluted. A volume of 50μl 
of sterile water was placed in three wells to determine background. 150μl of concentrated 
sulfuric acid was placed in each well. 30μl of a 5% phenol solution was pipetted into each 
well. The 96-well plate was then incubated at 37ºC for about 10 minutes. Plate was read 




 Samples were blocked in blocking buffer (1% bovine serum albumin (BSA) in 
1XPBS) for 30 minutes at room temperature. After, samples were washed once with 
blocking buffer. UVTex 2B (5/mL), and Nile Red (5/mL) were added with the primary 
mAbs (18B7, 2D10, 12A1) to blocking buffer. Primary mAbs were brought to a 
concentration of 10g/mL. Samples were set to incubate on a shaker at 30°C for 30 
minutes. Post incubation samples were washed 3 times with blocking buffer. Post-
washing FITC-secondary antibody conjugated at 2g/mL was added to blocking buffer 
then added to the samples. For 18B7 goat anti-mouse IgG was used. For 2D10, and 
12A1goat anti-mouse IgM was used as the secondary antibody. Samples were set to 
incubate on a shaker at 30°C for 30 minutes. Post incubation samples were washed 3 
times with blocking buffer. Slides were prepared using 3uL of India ink combined with 
6uL of sample.  
 
Exo-PS Prep for Neutron Scattering 
 A 3mL pre-culture of C. neoformans strain H99 was made in Sabouraud dextrose 
broth (SAB) media. This pre-culture was incubated on a circulating rack for 24 h at 30 
°C. The cells were then pelleted and washed with minimal media to remove the spent 
media. The pellet was then inoculated into a 1L culture of minimal media to induce 
capsule growth. The flask was placed on a shaker at 30 °C for 7 days. After the 7 days the 
culture was spun down to pellet the cells. The supernatant was then removed and run 
through a 0.22m vacuum filter to remove any lingering cells. This cell-free supernatant 
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was then run through an Amicon with a series of different sized membrane (100kDa, 
30kDa, 10kDa, and 1kDa). The gel collected from the 10kDa membrane was split into 





 The ultimate goal of this project was to determine what effect cavitation induced 
by sonication was having on the structural and compositional components of the capsular 
PS of C. neoformans. The following experiments were designed to test the effects of time 
in culture, survival, and cell density on the samples of C. neoformans used for cavitation 
experiments. Once each condition was optimized, the resulting experimental were applied 
thereafter to address the questions: what was the fate of the capsule structure post-
sonication, and where there any compositional changes in the PS post-sonication? 
 
4.1 Post-Sonication Images 
  
To determine the effect of sonication on overall structure of the PS I imaged C. 
neoformans pre and post-sonication using light microscopy and observations of pellets 
post-centrifugation.  
In figure 7, approximately 1x108 cells/mL were sonicated then centrifuged, and 
the volume of the pellets were observed by eye to determine that the post-sonication 
samples had a smaller sample volume.  This was the case for both melanized and non-




power level (1-10) on days 3, 5, and 7 (Figure 9). Non-melanized C. neoformans was 
used because it produces a larger capsule than melanized C. neoformans. Based on 
phenol-sulfuric acid assay, to detect all total carbohydrate concentration in a sample (data 
in figure 9), I determined that the day 7 culture had the highest overall levels of 
detectable carbohydrate. PS capsules are composed of polymeric carbohydrates, and the 
carbohydrate content was quantified using a phenol-sulfuric acid assay. Figure 9 also 
shows that a setting of 8, on a Fisher Scientific Sonic Dismembrator F550 W/ultrasonic 
Convertor, produced the highest level of carbohydrate which corresponds to the level of 
C. neoformans PS in the sample. Despite these results, a culture age of 5 days was chosen 
to continue the experiments. A 5-day old culture is more representative of the vegetative 
state of the C. neoformans capsule, as the composition changes with age.  
 
4.3 Effect of sonication on C. neoformans survival 
  
The survival of C. neoformans post-sonication was determined at a range of 
sonication levels to optimize the protocol. This was done by sonicating at levels 1-10 on 
the sonicator, with 1 having the lowest watts (RMS) power output and 10 the highest. All 
samples were sonicated for 30 seconds on 5-day-old cultures. There was an increase in 
the amount of capsule that was released from the sonicated cells as the power was 
increased. However, more cells were killed at the higher setting, as determined though 
tadpole assays. Tadpoling assays measure cell survival by measuring growth in a 96-well 
plate. The sample is put into the first row of the plate then diluted down the columns. 
Survival itself is determined by measuring the mean grey pixel value of each well using 
ImageJ. A higher mean grey value means more growth thus a higher survival rate. 
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Bransonic CPXH Ultrasonic Bath, Model 2800) and the use of the horn sonicator 
(Fisher Scientific Sonic Dismembrator F550 W/ultrasonic Convertor). The cells in the 
water bath were kept in for two hours on the high (40kHz) setting. For the horn sonicator 
(50-60kHz) C. neoformans was sonicated for 30 seconds at power setting 7 
(approximately 17 Watts (RMS)3). For the horn sonicator the output is given in Watts 
(RMS)4. The samples did rise in temperature post-sonication (on average by 16C5, but 
this did not reduce survival (no ice bath was used for the survival assay samples), or the 
amount of capsular PS released.6 This is based on an experiment where an ice bath was 
used to keep the sample from overheating. Capsule size measurement data (Figure 11) 
indicate that both methods are effective for reducing the diameter of the PS capsule of C. 
neoformans. However, based on the phenol-sulfuric acid assay results (Figure 12) the 
water bath method is not as effective in removing the capsule of C. neoformans. 
Therefore, I continued all subsequent experiments with the horn sonicator. 
                                                 
3 N=21 readings of the sonicator during experiments.  
4 More information on Watts (RMS) can be found in “Materials and Methods” under Sonication. 
5 N=14 before and after sonication temperature readings.  






recognition of the GXM antibodies in the ELISA means that the epitopes these antibodies 
bind to were either not present, or not present in sufficient quantity to allow for binding 
to occur. It is entirely possible that the GXM epitope for the antibody used in this ELISA, 
2D10, is damaged during sonication explaining why it is not able to be detected with this 
ELISA. 
 
4.6 Sonication of Isolated Exo-PS 
  
 A sample of 100kDa exo-PS, isolated using a 100kDa filter and Amicon 
filtration, was sonicated using the sonicator level of 7 (approximately 20 Watts (RMS) 
for 0, 15, 30, 45, and 60 seconds. DLS was then run on these samples to determine the 
effective diameter (size of the particle determined, by the machine, using the Stokes-
Einstein equation39,52) of the sample post-sonication. There is a change in the 
polydispersity of the PS in the samples as they undergo longer lengths of sonication. 
Polydispersity is a measure of heterogeneity within a sample with higher values 
corresponding to more size diversity within a sample.  
 From figure 15, I determined that after 60 seconds of sonication at level 7 the PS 
was broken into a more polydisperse sample, with a surprisingly high effective diameter. 
This not only indicates the PS is being cleaved through the use of sonication as the 
diameter decreases, but that the PS may be aggregating post-sonication. The aggregation 
is indicated by the larger effective diameter at the 60s time point as noted in figure 15. 
Aggregation of the PS would mean that the structure is being altered by sonication in a 
way that promotes subsequent binding together of particulate PS, possibly by exposing 








The PS capsule is the main virulence factor for C. neoformans. It inhibits 
phagocytosis by immune cells, interferes with complement, inhibits antibody production, 
and is necessary to cause disease.11,13,55 Fragility is the main problem involved when 
studying capsular components. It is composed of 95% to 99% water with the rest being 
GXM, GXM-Gal, and mannoproteins.6 These components form the layered, highly 
branched, and fragile PS capsule of C. neoformans.4,28 In this study several novel 
methods, including cavitation induced by ultra-sonication, and probing the exo-PS 
structure with SANS, and USANS, were used to explore the composition and structure of 
the PS, exo and capsular, of C. neoformans.  
This thesis project was initiated to determine if the layer of melanin deposited 
between the delimiting cell membrane and the polysaccharide (PS) capsule of C. 
neoformans contributes to the physical strength of C. neoformans cells when introduced 
to a physical force. Therefore, I subjected C. neoformans cells to multiple different 
physical stress conditions using cavitation induced by ultra-sonication. I did not see any 
increased protection in melanized C. neoformans when compared to non-melanized. For 
the initial experiments a water bath sonicator was used to induce cavitation. The water 
bath sonicator experiments did not reveal any cell breakage, so experiments were moved 
to the horn sonicator. At first breakage of C. neoformans was not seen. Once samples 
were centrifuged for longer post sonication there was noticeable breakage of cells within 
the sonicated samples. A noticeable reduction in capsule size post-sonication was seen 
using a phase contrast microscope using India ink preparations. This indicated that 
capsules were either lost or compressing. After running multiple tadpoling assays to 
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determine survival rates, the hypothesis that melanin could help protect C. neoformans 
from sonication was not supported (Figure 10). The reduction in capsule size was 
something that was further explored and became the basis for this thesis.  
One interesting finding was that sonication reduced the overall sample (Figure 7). 
The samples were initially the same concentration of cells/mL and despite this, it appears 
the sonicated samples had fewer cells/mL. This effect could be due to the PS of sonicated 
cells clumping together or maybe due to the reduction in capsule size post-sonication. 
The reduction in the PS capsule of C. neoformans was seen through the use of India ink 
imaging (Figure 8). India ink is used to see the PS capsule of C. neoformans as it 
provides contrast between the capsule and the background. India ink particles are too 
large to get into the PS capsule, so the capsule is seen as a halo around the cell body 
(Figure 8). 
One explanation about the reduction in the size of the C. neoformans capsule was 
that the capsule was collapsing due to cavitation, this is what I initially thought was 
happening. This hypothesis was disproven through the use of the phenol-sulfuric acid 
assay, and the GXM-capture ELISA. If the capsules were collapsing, there should have 
been no detectable carbohydrate and /or GXM in the supernatant of sonicated samples. 
This was not the case, however, as there were detectable levels of both in the supernatant 
of sonicated samples. Based on this evidence it was theorized that cavitation was 
breaking off parts of the PS capsule and these pieces were released into the supernatant.  
 For determining the best culture age to perform sonication with C. neoformans at 
3, 5, and 7 days were sonicated at settings 0-10. From here the supernatant was checked 
for carbohydrate concentration using a phenol-sulfuric acid assay. The cells were put into 
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a tadpole assay to determine survival. Based on the results from both of these assays all 
further experiments were run with culture that was 5 days old and the sonicator was set to 
7. C. neoformans at higher settings did release more PS into the supernatant and day 7 
cultures did have an increase in PS detected as well. The PS capsule is altered with age, 
which is why a younger culture was decided on despite a lower release in PS. A sonicator 
level of 7 was chosen because a good quantity of the cells remained alive post sonication.  
  The use of a water bath sonicator was tested into early in this project as they are 
standard in most labs and typically used to break up cells. Two samples of C. neoformans 
were prepped and placed in either a water bath for 2 hours or underwent the typically 
horn sonicator procedure (30 seconds at setting 7). Based on capsule radii measurements 
it was determined that the water bath did cause a reduction in capsule size. Next, a 
phenol-sulfuric acid assay was done to determine if the supernatant contained any PS 
compared to the horn-sonicated sample. There was no detectable PS in the water bath 
sonicated supernatant. Even when the water bath sonicated supernatant was compared to 
a sample that had a lower density of C. neoformans to begin with. Based on these results 
experiments using a water bath sonicator did not continue.  
 To see how much of an effect culture density had on detecting PS in the 
supernatant has samples containing different densities of C. neoformans were sonicated. 
The densities were 1x106,1x107, and 1x108 cells/mL. Each of these densities also had a 
control sample that was not sonicated. The phenol-sulfuric acid assays show that none of 
the controls or the 1x106cells/mL sonicated samples had detectable levels of PS in the 
supernatant. The sonicated samples with densities of 1x107, and 1x108 cells/mL did have 
detectable levels. 1x108 cells/mL samples contained the most detectable PS with a level 
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of 2.0mg/mL (Figure 13) This level was statistically significant compared to 
1x107cells/mL sonicated sample as determined using an un-paired t test.  
 Interestingly, the results from the GXM capture ELISA that was run on all the 
density samples did not detect a large amount of GXM in the supernatant of the sonicated 
1x108 cells/mL samples. This likely means that the PS is being broken up in a way that 
destroys the epitopes for GXM that 2D10, the primary antibody in the ELISA, bind to. 
Rather, the highest concentration of GXM was found in the 1x108 cells/mL un-sonicated 
samples (Figure 14). This could be due to exo-PS being shed into the supernatant during 
sample preparation, and the samples not being centrifuged enough to get all the PS out of 
the supernatant. This result supports the idea that sonication is breaking up the PS on the 
capsule of C. neoformans. It also indicates that sonication is changing the epitopes on the 
capsule. This hypothesis is further supported by the increase in mAb binding activity post 
sonication (Table 2).  
 Pure 10kDa PS, isolated through filtration from a culture of non-melanized C. 
neoformans was sonicated at different timepoints to determine how the samples would 
change. Using DLS to obtain polydispersity and effective diameter of the samples 
(Figure 15) there is a decrease in effective diameter, as expected, as time sonicated 
increases. There is a slight unexpected result in the 60 second timepoint as both the 
polydispersity and effective diameter of the sample increases. This may be due to some 
of the PS in the sample beginning to aggregate. The error bars for the 60 second sample 
are also quite large, so it is not clear if the results for this timepoint are as reliable as the 
others. As for the other timepoints the error bars are small and show a decrease in 
effective diameter as the samples are sonicated more. This indicates that the larger PS is 
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being broken into smaller pieces thus bringing down the average size of the PS. The 
polydispersity does not change too much from 0-45 seconds, though there is a slight 
decrease which indicates a slightly more monodisperse sample. This experiment shows 
that the exo-PS of C. neoformans can be broken into smaller pieces using sonication.  
 Perhaps the most intriguing result obtained from this project is the increased 
binding of antibodies post sonication (Table 2). This is interesting as it may lead to new 
insights on antibody epitopes on the PS capsule of C. neoformans, and virulence may be 
affected as the immune system may be able to better recognize and bind to the pathogen. 
The following mAbs were used for this part of the project: 12A1(IgM), 2D10 (IgM), 
18B7(IgG1). These are mAbs against the PS capsule of C. neoformans though they all 
bind with different affinities and the epitopes are not fully known. 12A1 in particular 
bound with much more affinity post sonication. 2D10 and 18B7 did not bind with as high 
of an affinity as 12A1.  
This leads to the question: What is being opened up in the capsule that allows for 
this increase in mAb binding? One hypothesis is that the epitope for 12A1 is contained on 
an inner layer (or structural component) of the PS capsule. Disruption of the capsule from 
sonication allows for this layer to be more exposed that usual, thus the mAb binding is far 
greater. This may also explain why the other mAbs also bind better post sonication, 
although it should be noted that the increase was not as great for 2D10, and 18B7.   
 The work at NIST with SANS and USANS is not complete. What the graphs 
(Figure 16, Figure 17) show is simply whether or not it is possible to observe scattering 
from the neutron beams. With the H2O exo-PS samples more work needs to be done in 
order to get scattering. It may be possible to run the samples on different instruments. 
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Presently, the concentration of the samples is not high enough to be able to get good 
neutron beam scattering. There are also problems with the polydispersity of the samples 
being too high. This means that the sample is to heterogenous, which makes neutron 
scattering more difficult. The data from the D2O samples is also not fully complied. 
However, for these samples there is scattering. With more modeling work a size and 





For the component on cavitation our results show that the PS capsule can be 
removed from C. neoformans within 30 seconds. The removed PS can be detected in the 
supernatant of the sonicated samples through both phenol-sulfuric acid assays, and GXM-
capture ELISA. The removal of PS capsule can be seen in India ink images as the cells 
post sonication have a reduction in capsule radii. There was also shown to be increased 
levels of binding post-sonication. This suggests that disruption of the capsule is revealing 
more epitopes for them to bind to on the PS.   
Sonication does not add any chemicals to the samples, such as DMSO, that may 
alter the chemical composition of the PS. This suggests that the PS that is released is in a 
more natural state then when treated with gamma irradiation or DMSO (Table 1). 
Dehydration of the PS capsule is also not a problem with this method as it keeps the 
sample in liquid. 
More work is needed to acquire data from NIST to determine whether or not 
scattering occurs. Neutron scattering data could theoretically provide more insight into 
the structure and composition of the PS of C. neoformans. More time needed for 
computer modeling of samples in order to make any conclusions about this data. Another 
problem is dealing with a high concentration of exo-PS as it turns into a thick gel making 
it hard to transfer into the holders that go into the SANS and USANS beams. Diluting the 
sample has been tried, but there is still not a good signal from either SANS or USANS.  
For future work it will be important to determine how this method affects the 
ability of C. neoformans to produce and maintain disease. It is possible that the increased 
ability of antibodies to bind to the capsule post-sonication would lead the immune system 
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to be able to clear the infection. The study could then test whether mice who were able to 
clear the infection were better protected from un-sonicated capsular C. neoformans. If the 
mice were able to better clear an infection from sonicated C. neoformans maybe the 
antibodies produced from this would better protect from further C. neoformans infection. 
Another aspect of this project that could still be explored is to determine how to use 
sonication, medically, to help clear infections with C. neoformans. Since sonication 
allows for better antibody binding would it may be possible to sonicate infected parts of a 
patient (mouse or human), and to stimulate their immune system clear the infection. 
Continuation of this work could also lead to further characterization of the capsule of C. 
neoformans in its natural state—research that is needed to advance the development of a 
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